Soleno Therapeutics
Signal active
Organization
Contact Information
Overview
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
About
Industries
Biotechnology, Pharmaceutical, Medical
Founded
1999
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Soleno Therapeutics headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $15.3B in funding across 48 round(s). With a team of 11-50 employees, Soleno Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Soleno Therapeutics, raised $158.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$319.2M
Details
0
Soleno Therapeutics has raised a total of $319.2M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Soleno Therapeutics is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Adage Capital Management | - | FUNDING ROUND - Adage Capital Management | 129.0M |
| Frazier Life Sciences | - | FUNDING ROUND - Frazier Life Sciences | 129.0M |
| Soleno Therapeutics | - | FUNDING ROUND - Soleno Therapeutics | 129.0M |
| Perceptive Advisors | - | FUNDING ROUND - Perceptive Advisors | 129.0M |
Recent Activity
There is no recent news or activity for this profile.